(EMAILWIRE.COM, June 21, 2017 ) Browse 100 market data Tables and 41 Figures spread through 159 Pages and in-depth TOC on "In Vitro Fertilization Market"
http://www.marketsandmarkets.com/Market-Reports/in-vitro-fertilization-market-89198891.html
Early buyers will receive 10% customization on this report.

Growth in the media age of first-time motherhood, growing cases of male infertility, and declining fertility rates are the major factors driving the growth of the global in vitro fertilization (IVF) market.

Some of the other factors driving the growth of this market includes growth in healthcare expenditure, rise in consumption of alcohol and cigarettes, implementation of government initiatives and introduction of new and advanced products.

Download PDF Brochure@
http://www.marketsandmarkets.com/pdfdownload.asp?id=89198891

However, high cost coupled with low success rate, and restrictive regulation and ethical concerns are expected to restrain the growth of this market to a certain extent. Moreover, reduction in the efficacy of the infertility treatment with advancing age is the major challenge faced by the IVF market players operating in the global IVF market.

In the coming years, the APAC region is expected to witness the highest growth rate in the in vitro fertilization market. Factors such as high maternal age in Japan, abolishment of China’s one child policy, rising fertility tourism in India and Thailand, growing surrogacy and high prevalence of PCOS in India and growing number of ART procedures in Australia and New Zealand are driving the IVF market in the APAC region.

Get The Sample Pages Of This Report:
http://www.marketsandmarkets.com/requestsample.asp?id=89198891

In this report, the global in vitro fertilization (IVF) market is segmented on the basis of technology, product, end user, and region.

CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), ESCO Micro Pte. Limited (Singapore), Genea Limited (Australia), The Baker Company (U.S.), IVFtech ApS (Denmark) and EMD Serono, Inc. (U.S.) are some of the key players in the global in vitro fertilization market.

Target Audience:

• Medical Device Industry
• Hospitals and Research Laboratories
• Academic Centers
• Fertility and Surgical Centers
• Suppliers/Distributors
• Manufacturers

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441